Literature DB >> 33562468

Amphiregulin Regulates Melanocytic Senescence.

Michaela Pommer1, Silke Kuphal1, Anja K Bosserhoff1,2.   

Abstract

Oncogene-induced senescence (OIS) is a decisive process to suppress tumor development, but the molecular details of OIS are still under investigation. Using an established OIS model of primary melanocytes transduced with BRAF V600E and compared to control cells, amphiregulin (AREG) was shown to be induced. In addition, AREG expression was observed in nevi, which by definition, are senescent cell clusters, compared to melanocytes. Interestingly, treatment of melanocytes with recombinant AREG did induce senescence. This led to the assumption that extracellular AREG has an important function in this process. Inhibition of the epidermal growth factor receptor (EGFR) using Gefitinib identified AREG as one of EGFR ligands responsible for senescence. Furthermore, depletion of AREG expression in senescent BRAF V600E melanocytes resulted in a significant reduction of senescent melanocytes. This study reveals AREG as an essential molecular component of signaling pathways leading to senescence in melanocytes.

Entities:  

Keywords:  AREG; OIS; amphiregulin; normal human primary melanocytes; oncogene induced senescence

Year:  2021        PMID: 33562468      PMCID: PMC7914549          DOI: 10.3390/cells10020326

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  38 in total

1.  Expression of oncogenic BRAFV600E in melanocytes induces Schwannian differentiation in vivo.

Authors:  Chi Luo; Jodie R Pietruska; Jinghao Sheng; Roderick T Bronson; Miaofen G Hu; Rutao Cui; Philip W Hinds
Journal:  Pigment Cell Melanoma Res       Date:  2015-06-20       Impact factor: 4.693

2.  Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.

Authors:  Marie Guerard; Thomas Robin; Pascal Perron; Anne-Sophie Hatat; Laurence David-Boudet; Laetitia Vanwonterghem; Benoit Busser; Jean-Luc Coll; Sylvie Lantuejoul; Beatrice Eymin; Amandine Hurbin; Sylvie Gazzeri
Journal:  Cancer Lett       Date:  2018-02-06       Impact factor: 8.679

Review 3.  Cellular senescence in the development and treatment of cancer.

Authors:  Gabriele Saretzki
Journal:  Curr Pharm Des       Date:  2010-01       Impact factor: 3.116

4.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms.

Authors:  Claes Bavik; Ilsa Coleman; James P Dean; Beatrice Knudsen; Steven Plymate; Peter S Nelson
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 5.  Senescence in Health and Disease.

Authors:  Shenghui He; Norman E Sharpless
Journal:  Cell       Date:  2017-06-01       Impact factor: 41.582

6.  Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.

Authors:  V K Goel; N Ibrahim; G Jiang; M Singhal; S Fee; T Flotte; S Westmoreland; F S Haluska; P W Hinds; F G Haluska
Journal:  Oncogene       Date:  2009-04-27       Impact factor: 9.867

7.  Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding.

Authors:  Timo Effenberger; Jan von der Heyde; Kareen Bartsch; Christoph Garbers; Klaus Schulze-Osthoff; Athena Chalaris; Gillian Murphy; Stefan Rose-John; Björn Rabe
Journal:  FASEB J       Date:  2014-07-30       Impact factor: 5.191

Review 8.  MIA--a new target protein for malignant melanoma therapy.

Authors:  Jennifer Schmidt; Alexander Riechers; Anja-Katrin Bosserhoff
Journal:  Histol Histopathol       Date:  2012-11-22       Impact factor: 2.303

9.  Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

Authors:  V C Gray-Schopfer; S C Cheong; H Chong; J Chow; T Moss; Z A Abdel-Malek; R Marais; D Wynford-Thomas; D C Bennett
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

10.  Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun's Nuclear Translocation and Activity.

Authors:  Melanie Kappelmann-Fenzl; Silke Kuphal; Rosemarie Krupar; Dirk Schadendorf; Viktor Umansky; Lily Vardimon; Claus Hellerbrand; Anja-Katrin Bosserhoff
Journal:  Cancers (Basel)       Date:  2019-11-17       Impact factor: 6.639

View more
  3 in total

1.  Alpha-Synuclein and Its Role in Melanocytes.

Authors:  Nicole Rachinger; Nora Mittag; Ines Böhme-Schäfer; Wei Xiang; Silke Kuphal; Anja K Bosserhoff
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

2.  Vemurafenib Drives Epithelial-to-Mesenchymal Transition Gene Expression in BRAF Inhibitor‒Resistant BRAFV600E/NRASQ61K Melanoma Enhancing Tumor Growth and Metastasis in a Bioluminescent Murine Model.

Authors:  Jana Jandova; Georg T Wondrak
Journal:  J Invest Dermatol       Date:  2021-10-21       Impact factor: 7.590

3.  Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma.

Authors:  Ines Böhme-Schäfer; Sandra Lörentz; Anja Katrin Bosserhoff
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.